MOUNTAIN VIEW, Calif., July 24, 2014 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, July 31, to discuss the Company's Second Quarter 2014 financial results.
What: Omnicell Second Quarter 2014 earnings conference call and webcast When: July 31, 2014, 1:30 p.m. PT Who: Randall Lipps, chairman, president and chief executive officer Rob Seim, chief financial officer Where: The conference call can be monitored by dialing 1-800-696-5518 within the U.S. or 1-706-758-4883 for all other locations. The Conference ID # is 76720101. The webcast can be accessed at: http://ir.omnicell.com/events.cfm. How: Link to the Omnicell website 15 minutes prior to the call to download necessary audio software. Replay: Available starting at 4:30 p.m. PT on July 31, 2014 through 4:30 p.m. PT on August 15, 2014. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 76720101.
Since 1992, Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum-- from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
More than 2,800 customers worldwide have utilized Omnicell Automation and Analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Medication Adherence solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions to help reduce costly hospital readmissions. In addition, these solutions enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
SOURCE Omnicell, Inc.